Series A - Enthera

Series A - Enthera

Investment Firm

Overview

Enthera is a biotech manufacturing company that develops biotherapeutics treatments for underserved auto-immune disorders.

Announced Date

Jan 28, 2021

Funding Type

Series A

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Roche Venture Fund

Roche Venture Fund

Roche Venture Fund is a early_stage_venture and late_stage_venture firm.

Participant Investors

1

Investor Name
Participant InvestorRoche Venture Fund

Round Details and Background

Enthera raised $8483995 on 2021-01-28 in Series A

Enthera is a biotech manufacturing company that develops biotherapeutics treatments for underserved auto-immune disorders.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 25, 2018
Seed Round - Enthera
1-4.7M
Jul 28, 2020
Series A - Enthera
6-32.8M
Jan 28, 2021
Series A - Enthera
1-8.5M

Recent Activity

There is no recent news or activity for this profile.